The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
CorrectionFull Access

Correction

Published Online:https://doi.org/10.1176/pn.36.3.0004c

The article “Psychotherapy Shows Great Benefit in Treatment of Schizophrenia Patients” in the November 17 issue, contained some incorrect information. William Gottdiener, Ph.D., is not in private practice; he is a psychotherapist for a community mental health center. He is also a postdoctoral fellow in drug abuse research at Medical and Health Research Association of New York City Inc. and the National Development and Research Institutes Inc. and a candidate in psychoanalytic training at the New York Psychoanalytic Institute. The meta-analysis discussed in the article was conducted with Nick Haslam, Ph.D., a faculty member at the New School University in New York City.